Mounjaro®
Starting from £179.99/mo
Start journey Learn moreA Mounjaro KwikPen holds 0.6ml of solution and delivers four once-weekly doses of 0.15ml each — the volume stays the same across every strength, from 2.5mg to 15mg. If you have seen "0.6ml Mounjaro" on packaging or in instructions, it refers to the total fill of a single KwikPen, not a dose level or a strength. These are prescription-only medicines; a GPhC-registered prescriber assesses clinical suitability before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A question our prescribers hear regularly is whether 0.6ml is a dose someone should be measuring out or requesting from a pharmacy. It is neither. If you want a closer look at exactly what is inside the device, our page on the 0.6ml Mounjaro pen explains what that figure represents and why it appears on the carton. Eli Lilly manufactures every strength of the pen (from the 2.5mg starter through to the 15mg maintenance strength) with exactly the same fill volume of 0.6ml. What changes between strengths is how much active medicine (tirzepatide) is dissolved in that fixed volume of solution.
This matters because Mounjaro is a pre-filled, pre-set device. You do not draw up a volume yourself, and you cannot adjust it. Each time you press the injection button, the pen releases 0.15ml automatically. Four injections, four weeks, one pen. There is no dial, no syringe, no calculation required. If you are wondering about the mechanics of the device in more detail, the Mounjaro overview page covers how the KwikPen works from start to finish.
The confusion is understandable. Older injectable medicines and compounded products are sometimes described by volume rather than dose, and some people encounter the 0.6ml figure on the outer carton or in the Patient Information Leaflet before they have had a chance to read it carefully. Knowing that the volume is fixed removes one layer of worry before treatment begins.
Look at a Mounjaro carton and you will see two pieces of information sitting close together: the strength in milligrams (say, 5mg) and the fill volume (0.6ml). The strength is the clinically meaningful figure. It tells you how much tirzepatide reaches your system with each weekly injection. The 0.6ml is manufacturing information, a quality-control confirmation that the pen has been filled to the correct level.
Mounjaro is a dual GIP and GLP-1 receptor agonist, activating two appetite-regulating pathways simultaneously. The dose your prescriber chooses determines how strongly those pathways are activated. The tirzepatide information page goes into the mechanism in more depth if that is useful background. What the 0.6ml figure cannot tell you is which strength is right for you, that depends on how your body has responded to earlier doses, your current weight, any side effects you have noticed, and your prescriber's clinical judgement.
The licensed titration schedule starts at 2.5mg. That first pen exists to help your digestive system adjust rather than to produce immediate weight loss; the therapeutic effect builds as doses increase over subsequent months, always guided by a prescriber. Once titration progresses, many patients move on to a higher maintenance dose, and our guide to the 5mg Mounjaro pen explains what to expect at that stage of treatment.
Because the question of volume comes up most often when someone is new to Mounjaro, it is worth addressing a few practical points that tend to follow it. First, the pen must be stored in a fridge at 2–8°C until first use. There is a limited window for keeping it at room temperature, but the exact period is specified in the Patient Information Leaflet and varies by product batch; always defer to that document rather than a general figure you have read online. The NHS tirzepatide medicines page gives a reliable patient-level summary of storage and handling.
Second, the fill volume does not affect how you prime or use the pen. The steps in the Patient Information Leaflet apply to all six strengths. You check the dose indicator window, choose your injection site (abdomen, thigh, or upper arm, rotating each week), and press the button until the indicator shows the dose has been delivered. If the window shows the pen has not fully discharged, the leaflet explains what to do, and so do the prescribers on our clinical team. You can read about the clinical team's approach on the clinical team page.
Third, some people ask whether a 0.6ml pen delivers less medicine than a larger-volume device they may have seen. It does not. Volume and potency are separate things. A concentrated solution in 0.6ml can deliver a higher dose than a dilute solution in a larger volume. If you would like a fuller picture of how the pen works and what that figure on the label really means, our page on ml and Mounjaro brings together the key details in one place. If you have questions about cost alongside your treatment, the Mounjaro cost context page sets out what private pricing typically reflects and why clinical oversight is part of what you are paying for.
Mounjaro is a Prescription-Only Medicine. In the UK the licensed eligibility for weight management is a body mass index of 30 or above, or 27 or above alongside at least one weight-related condition such as high blood pressure, high cholesterol, or type 2 diabetes. Lower BMI thresholds apply for some ethnic backgrounds under UK clinical guidance. BMI alone does not guarantee approval; a prescriber reviews the full picture, including other medicines you take, your medical history, and any contraindications. The weight-loss treatment overview covers eligibility in more detail.
At nume, every consultation is read by a GPhC-registered Independent Prescriber on the same day it is submitted, a real clinician, not software. Identity and weight are verified, and the prescriber decides on suitability before anything is dispensed. If you order before midday on a weekday and are approved, your treatment leaves our pharmacy the same day and arrives free, via tracked DPD delivery, the next working day. Plain, unbranded packaging. Nothing hidden in the price. If you are unsure about your situation or have a specific question before starting, the FAQs and contact page are there for exactly that. When you are ready to take the next step, checking your eligibility takes a few minutes and costs nothing.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.